GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

But Lynparza is only approved as a maintenance therapy in Europe, in patients with BRCA1 and BRCA2 mutations with recurrent disease, when the tumour is diminishing in size or has disappeared after ...

Chronic hepatitis B (CHB) is a long-term infection of the liver caused by the hepatitis B virus (HBV). While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the ...

GlaxoSmithKline raised eyebrows last year when it paid $5.1 billion for Tesaro and its PARP inhibitor Zejula, amid suggestions it had paid too much. Now, a positive phase 3 trial for the drug will ...

Lois Borny works on the product review section of The Independent, IndyBest, where she helps readers to save money and shop savvy, scouting out the very best deals and sharing her tried and tested ...